A Study to Assess the Efficacy and Safety of Budesonide/Albuterol Metered-dose Inhaler (BDA MDI/PT027) in Adults and Children 4 Years of Age or Older With Asthma

NCT03769090 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

3132

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

COMBINATION_PRODUCT: Budesonide/albuterol sulfate metered-dose inhaler 160/180 μg
COMBINATION_PRODUCT: Budesonide/albuterol sulfate metered-dose inhaler 80/180 μg
DRUG: Albuterol sulfate metered-dose inhaler 180 μg

Sponsor

Bond Avillion 2 Development LP